Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00447798 · ClinicalTrials.gov registry record · NA
Project Hope: Hospital Visit is an Opportunity for Prevention and Engagement With HIV-positive Crack Users
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 413
- Enrollment target
NCT00447798: Completed NA study, sponsored by Columbia University.
NCT00447798 is a NA study that has completed, run by Columbia University. The registered enrollment target is 413 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00447798, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 413 participants
- Enrollment target
Study Summary
The proposed study uses a two-arm randomized experimental design to evaluate the efficacy of a brief, theoretically-guided, "Prevention Care Advocate" intervention with HIV-positive crack users. Study participants will be recruited from the HIV inpatient hospital wards of two inner-city hospitals that serve a similar population of HIV-positive patients: Jackson Memorial Hospital (JMH) in Miami, Florida and Grady Memorial Hospital (GMH) in Atlanta, Georgia.
Interventions
- BEHAVIORAL Prevention Care Advocate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 413 participants |
| Start Date | 2005-06 |
| Est. Completion | 2011-05 |
| Phase | NA |
What the finished NCT00447798 record still lists
NCT00447798 is an interventional study that assigns participants to a tested intervention. The registered 413 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower).
The record links to 0 conditions, and to 1 intervention - of which Prevention Care Advocate is the first listed.
NCT00447798 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00447798 about?
NCT00447798 is a clinical study titled "Project Hope: Hospital Visit is an Opportunity for Prevention and Engagement With HIV-positive Crack Users". The proposed study uses a two-arm randomized experimental design to evaluate the efficacy of a brief, theoretically-guided, "Prevention Care Advocate" intervention with HIV-positive crack users. Study participants will be recruited from the HIV inpatient hospital wards of two inner-city hospitals th...
What is the current status of trial NCT00447798?
This trial is currently completed. It is a NA study. The enrollment target is 413 participants. The study started on 2005-06. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00447798?
The interventions under investigation include: Prevention Care Advocate (BEHAVIORAL).
Who is sponsoring clinical trial NCT00447798?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00447798's enrollment target sits among peer trials
413 241st of 2000 higher than 1,760 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03592472 · 413 participants · Phase 3
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
- NCT06697197 · 413 participants · Phase 1
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
- NCT04776941 · 414 participants · NA
Expressive Writing for the Management of Stress in Cancer Survivors
- NCT06792552 · 414 participants · Phase 1
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia